Your browser doesn't support javascript.
loading
Monitoring multidimensional aspects of quality of life after cancer immunotherapy: protocol for the international multicentre, observational QUALITOP cohort study.
Vinke, Petra C; Combalia, Marc; de Bock, Geertruida H; Leyrat, Clémence; Spanjaart, Anne Mea; Dalle, Stephane; Gomes da Silva, Maria; Fouda Essongue, Aurore; Rabier, Aurélie; Pannard, Myriam; Jalali, Mohammad S; Elgammal, Amal; Papazoglou, Mike; Hacid, Mohand-Said; Rioufol, Catherine; Kersten, Marie-José; van Oijen, Martijn Gh; Suazo-Zepeda, Erick; Malhotra, Ananya; Coquery, Emmanuel; Anota, Amélie; Preau, Marie; Fauvernier, Mathieu; Coz, Elsa; Puig, Susana; Maucort-Boulch, Delphine.
Afiliação
  • Vinke PC; Epidemiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands p.c.vinke@umcg.nl susipuig@gmail.com.
  • Combalia M; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain.
  • de Bock GH; Dermatology, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
  • Leyrat C; Epidemiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  • Spanjaart AM; Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.
  • Dalle S; Hematology, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
  • Gomes da Silva M; Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Fouda Essongue A; LYMMCARE, Amsterdam, The Netherlands.
  • Rabier A; Dermatology, Cancer Research Center of Lyon, Lyon Sud Hospital, Pierre-Bénite, France.
  • Pannard M; University Claude Bernard Lyon 1, Villeurbanne, France.
  • Jalali MS; ImmuCare, Cancer Institute of the Hospices Civils de Lyon, Lyon, France.
  • Elgammal A; Hematology, Portuguese Institute of Oncology, Lisboa, Portugal.
  • Papazoglou M; ImmuCare, Cancer Institute of the Hospices Civils de Lyon, Lyon, France.
  • Hacid MS; ImmuCare, Cancer Institute of the Hospices Civils de Lyon, Lyon, France.
  • Rioufol C; INSERM Unit U1296 Radiation: Defence, Health, Environment, Lumière University Lyon 2 Psychology Institute, Bron, France.
  • Kersten MJ; MGH Institute for Technology Assessment, Harvard Medical School, Boston, Massachusetts, USA.
  • van Oijen MG; Scientific Academy for Service Technology e.V. (ServTech), Potsdam, Germany.
  • Suazo-Zepeda E; Egypt University of Informatics, Cairo, Egypt.
  • Malhotra A; Scientific Academy for Service Technology e.V. (ServTech), Potsdam, Germany.
  • Coquery E; School of Computer Science and Engineering, University of New South Wales, Sydney, New South Wales, Australia.
  • Anota A; School of Computing, Macquarie University, Sydney, New South Wales, Australia.
  • Preau M; LIRIS, CNRS UMR 5205, Universite Claude Bernard Lyon 1, Villeurbanne, France.
  • Fauvernier M; Clinical Oncology Pharmacy Department, Hospital Lyon-South, Cancer Institute of the Hospices Civils de Lyon, Pierre-Benite, France.
  • Coz E; Hematology, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
  • Puig S; Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Maucort-Boulch D; LYMMCARE, Amsterdam, The Netherlands.
BMJ Open ; 13(4): e069090, 2023 04 27.
Article em En | MEDLINE | ID: mdl-37105689
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article